About Sanify Pharmacare Private Limited
Data last updated:
Sanify Pharmacare Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24233MP2013PTC031585. Its GSTIN is 23AATCS7154D1Z6 (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ritu Rao and Andhru Sabhapati Rao.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Cv – A 33 Dreamcity Talawali Chanda Mangliya, Indore, Madhya Pradesh, India – 453771.
As per the financials filed for FY 2025, the company reported a revenue of ₹1 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹56,601 (net margin 0.6%) and EBITDA of ₹1.83 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanifypharmacare.com.
Company details
Contact details
Sanify Pharmacare Private Limited's registered office is in Indore, Madhya Pradesh. Its website is sanifypharmacare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressCv – A 33 Dreamcity Talawali Chanda Mangliya, Indore, Madhya Pradesh, India – 453771
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sanify Pharmacare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sanify Pharmacare is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sanify Pharmacare Private Limited, buy the company report.
Financials of Sanify Pharmacare Private Limited
FY 2025 filings availableSanify Pharmacare Private Limited reported revenue of ₹1 Cr (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 30% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56,601 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanify Pharmacare Private Limited, buy the company report.
Board of directors of Sanify Pharmacare Private Limited
Sanify Pharmacare has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritu Rao | Director | 08 Oct 2013 | 13 Years 0 Months | Current |
| Andhru Sabhapati Rao | Director | 08 Oct 2013 | 13 Years 0 Months | Current |
Auditor
Sanify Pharmacare Private Limited is audited by ASHISH K VYAS & CO for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHISH K VYAS & CO | FY 2016 | 010411C |
Shareholding
The shareholding of Sanify Pharmacare Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sanify Pharmacare Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sanify Pharmacare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanify Pharmacare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sanify Pharmacare has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AATCS7154D1Z6 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sanify Pharmacare Private Limited, buy the company report.
Recent activity
Sanify Pharmacare Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Andhru Sabhapati Rao was appointed as Director on 08 Oct 2013.
Frequently asked questions
Sanify Pharmacare is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 October 2013 (13+ years old) and is registered under CIN U24233MP2013PTC031585.
Sanify Pharmacare has 2 current directors:
- Ritu Rao - Director
- Andhru Sabhapati Rao - Director
The latest financial statements of Sanify Pharmacare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sanify Pharmacare is 23AATCS7154D1Z6, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Sanify Pharmacare is U24233MP2013PTC031585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanify Pharmacare was incorporated on 08 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Gwalior.
Andhru Sabhapati Rao was appointed as Director on 08 Oct 2013. Ritu Rao was appointed as Director on 08 Oct 2013.
Sanify Pharmacare can be reached through the website sanifypharmacare.com. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Sanify Pharmacare is at Cv – A 33 Dreamcity Talawali Chanda Mangliya, Indore, Madhya Pradesh, India – 453771.
Sanify Pharmacare operates in the pharma industry, in the drug formulation and development segment.